To evaluate the impact of a Diabetes Specialist Nurse prescriber on insulin and oral hypoglycaemic agent medication errors and length of stay.
Background
The National Health Service has committed to a 40% reduction in the number of drug errors in the use of prescribed medicines. Drug errors in diabetes care are a common cause of significant morbidity and complications. Nurse prescribing creates an opportunity for nurses to improve care for these patients.
Design
A quasi-experiment using six wards in a single hospital trust.
Methods
In-patient care of a convenience sample of patients with diabetes was evaluated before (n=27) and after (n=29) the intervention of a Diabetes Specialist Nurse prescriber.
Prospective data was collected to measure insulin and oral hypoglycaemic medication errors and length of stay.
Results
There was a significant reduction in the total number of errors between the preintervention and intervention group (mean reduction 21 errors) (p=0.016). The median length of stay was reduced by three days. The total number of errors and length of stay were affected by admission category (p=0.0004).
Conclusions
A medicines management intervention, provided by a Diabetes Specialist Nurse prescriber, had a positive effect on the system of delivering medicines to patients with diabetes, and significantly reduced the number of errors. This reduction had some
INTRODUCTION
Since 1997 a large number of radical reforms have been introduced within the National Health Service (NHS) in an attempt to control cost and improve quality (Department of Health (DoH) 1998 , DoH 2000 . Such reforms have increasingly become an essential requirement of service delivery. In NHS organisations in the United Kingdom (UK) the incidence of medication error (ME) is one specific indicator of quality that has been adopted to demonstrate medication safety (DoH 2004) . Although, the majority of MEs do not result in harm to the patient, it is suggested that the direct costs of medication errors in the NHS hospitals are £200-400 million per year (DoH 2004) . It is evident from the literature that patients who suffer adverse events and/or medication errors also experience an increased length of stay (LOS) of between 2-8 days (Wilson et al. 1995 , Classen et al. 1997 , Vincent et al. 2001 ).
The National Patient Safety Agency recently adopted the following definition of medication error (DoH 2004 P20): medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of health professional, patient or consumer.
Patients with diabetes occupy approximately 10% of hospital in-patient beds and are likely to be admitted to hospital twice as often and stay twice as long as people without diabetes (Currie et al. 1997) . Errors in diabetes care, which patients experience during admission to hospital, are also a common cause of significant
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Page number morbidity and complications (Hellman 2001) . A lack of information, inappropriate amounts and timings of meals, unnecessary side effects from medicines, delayed hospital discharge and prolonged admission as a result of errors in the medication process, are all identified shortfalls at a national level in the diabetes service (Hiscock et al. 2001 , van der Bijl & Shortridge-Baggett 2001 , Fan et al. 2005 .
A quarter of people living with this disease also experience three or more other longterm conditions (DoH 2003a) . The number of co-morbidities is also linked to the number of medication related problems a patient is likely to experience (Manley et al. 2003) . Furthermore, patients with diabetes (who are more likely to have complex medicine regimens) do experience more medication related problems. The DoH has estimated that £5 million a day is spent by the NHS on treatment for diabetes and its related complications (DoH 2003a). Additionally, the NHS has committed to reducing by 40% the number of serious drug errors in the use of prescribed drugs (DoH 2004) . Therefore reducing MEs in diabetes care for patients admitted to hospital is one way that significant improvement to care and sustainable savings to the NHS can be achieved.
BACKGROUND
There is substantial evidence to suggest that most MEs involve a chain of problems, and a wide variety of contributing factors that need to be considered (Vincent 2003 , Dean et al. 2002 , Hellman 2001 , Leape 1999 , Reason 1990 . Reason (1990 ), Vincent et al. (1998 and Dean et al. (2002) describe two types of error; slips and lapses and mistakes. Slips and lapses are errors of action and occur when there is a break in routine and attention is diverted. In comparison, mistakes, which are more difficult to detect, are rule and knowledge based errors and are errors of conscious thought. They commonly occur from a lack of knowledge or misperception of the situation with the subsequent application of the wrong rule to the situation.
The process of providing medications to patients is complex involving multiple sub processes (Clancy 2004). Many specific factors have been associated with prescribing and medication errors including calculations of drug dose, errors in decimal points, medications with similar names, medication dosage forms, use of abbreviations, unusual routes of drug administration, uncommon dosage regimens, complicated dosage regimens, poor history taking, lack of knowledge of the drug and patient, work load, and failure to follow policy and procedure (Leape et al. 1995 , Lesar et al. 1997 , O'Shea 1999 , DoH 2004 . In an evaluation of medication errors Leape et al. (1995) discovered that 39% of errors occurred during physician ordering, 38% during administration by nurses, and the remainder were equally divided between pharmacy and transcription.
Insulin has been identified as one of the top five medications associated with medication errors that cause harm to patients (Kowiatek et al. 2001) . In a recent initiative to reduce insulin medication errors Kowiatek et al. (2001) conducted a one year evaluation and review of medication errors. The majority of errors were classed as wrong dose/rate, omission and incorrect drug. A more detailed analysis identified that prescribing and transcribing errors were also related to inappropriate use of abbreviations (use of word 'unit' vs. 'u' and no zeros after whole numbers), and a lack of instruction and training on how to write insulin orders.
Interventions from hospital Diabetes Specialists Nurses (DSNs) include a strong emphasis on patient education, support, advice, and medicines management (Cavan et al. 2001 , Young et al. 2002 , Barr-Taylor et al. 2003 , Chan et al. 2006 ). These interventions have been shown to improve glycemic control and decrease LOS (Koproski et al. 1997 , Thompson et al. 1999 , Grey et al. 2002 , Wong et al. 2005 , Sampson et al. 2006 . However, only minimal research has examined nurse prescribing in diabetes (James 2004 , Courtenay et al. 2007 . Qualified Nurse Independent/Nurse Supplementary Prescribers (DoH 2003b , DoH 2006a ) are able to prescribe any licensed medicine (and some controlled drugs) independently or, any medicine as a supplementary prescriber (provided that these medicines are within the prescribers area of competence). Supplementary prescribing takes place after an assessment and diagnosis of a patients condition has been made by a doctor, and a clinical management plan (which includes a list of medicines from which the supplementary prescriber is able to prescribe) has been agreed between the nurse prescriber, doctor and patient.
Although errors are an intrinsic part of mental functioning and cannot be totally eliminated (Reason 1990) , there is considerable evidence to suggest the fundamental cause usually lies in a variety of systemic features operating at the level of the task, the work environment, and wider organisational context (Reason 1990 , Leape 1999 , Hellman 2001 , Vincent 2003 , DeLisa 2004 . The primary objective of a system design for safety is to make it difficult for individuals to err (Leape 1994) . Ideally a system, as Leape suggests, will automatically correct errors or have mechanisms in place to at least detect errors in time for corrective action.
It is evident that errors frequently occur in the prescription of insulin, and the education of healthcare professionals is a factor contributing to these errors (Kowiatek et al. 2001) . Therefore, nurse prescribing (which provides a mechanism to educate and support patients and staff (National Prescribing Centre 2005)(NPC)) creates a new opportunity for nurses to provide care designed to have a positive effect on the system for prescribing and administering insulin and or insulin and oral hypoglycaemic agent (OHA) medicines to patients with diabetes.
THE STUDY

Aim
The aim of the study was to compare insulin and OHA medication errors, and LOS between a comparison group receiving standard inpatient care and an intervention group who had their medicines managed by a DSN prescriber. The specific research questions were:  Do patients treated by a DSN prescriber experience a reduction in the number of insulin and OHA medication errors?  Do patients treated by a DSN prescriber experience a reduction in LOS?
Design
The study was a quasi-experiment carried out using six medical (including renal) and surgical (including orthopaedics, vascular surgery no amputation and vascular surgery) wards in a District General Hospital in the UK between May-December
2005.
Sample
Subjects were a convenience sample of 56 patients with diabetes admitted onto one of the six wards during a three month pre-intervention phase, and three month intervention period with a predicted length of stay at least three days. Agreement from wards to participate in the study was obtained from ward managers. Seven patients in the pre-intervention group were readmitted twice. In the intervention group three patients were readmitted twice and one three times. These patients were readmitted for reasons other than their diabetes e.g. heart failure, renal disease and chemotherapy.
All participants were part of a larger study, the results of which have been reported elsewhere (Courtenay et al. 2007 ).
Intervention
Within the Hospital Trust nursing and administrative staff identified several factors that appeared to affect the level of care patients in hospital with diabetes received (James 2003) . The main areas of concern related to delays in diabetes treatment, inaccuracies in prescriptions for insulin or OHA, access to information about systems of delivery, gaps in knowledge about diabetes and its treatment, access to diabetes health professionals and lack of continuity of diabetes care. It is evident that these areas of concern were rooted across all parts of the medication system for patients with diabetes who are prescribed insulin and/ or OHA. The medicines management intervention was therefore designed to address these factors.
During the first three months (pre-intervention phase) patient's received standard care
i.e. their medicines were prescribed and managed by medical i.e. house officers, senior house officers and non-diabetes specialist registrars and nursing staff other than a DSN prescriber. Following a 1 month period designed to enable ward staff to adjust to a nurse-led service, data was collected for a further three months (intervention period). During this period, in addition to standard care, patients received care and advice from a DSN prescriber. This included an initial patient assessment by the DSN prescriber (including review of medicines regime), 1-3 individual patient education sessions appropriate to need (information was provided on the patients condition, management of medicines, any medication changes), and on-going review of patients medicines regime. The need for frequency and content of education sessions was based on the initial patient assessment.
During the intervention period the DSN prescriber also provided medical and nursing staff with 1-2 individual education sessions appropriate to need. These sessions comprised information on the treatment regimes of each patient including drug action and dose, drug interactions and adverse effects. Nurse supplementary prescribing was instigated in the absence of medical staff, in an emergency, or, if a delay in prescribing would adversely affect the patient.
Outcome measures and data collection
The two main outcome measures were insulin and oral hypoglycaemic medication errors, and LOS.
Medication errors
The findings from a preliminary audit (James 2003) undertaken within the hospital trust had identified a number of errors with regards to the prescribing of insulin and oral therapy. These errors were classifiable into 14 different categories. As part of the larger study (and reported elsewhere) an error chart (see Table 1 ), which described and categorised the range of possible insulin errors was developed and piloted from this information (Courtenay et al. 2007 ).
During the pre-intervention and intervention phases of the study, patient's medication charts (including the insulin and/or insulin infusion chart) were collected upon patient discharge. These charts were photocopied and made anonymous and reviewed blind by a researcher with a background in diabetes research. Any errors identified within the 14 categories were then recorded on the insulin and OHA error chart (one chart per person). In order to increase the robustness of this process, and as part of the larger study, the first 20 error charts and medication charts from which these errors were extracted, were reviewed by a Consultant Diabetologist (JR) (Courtenay et al. 2007 ). There was agreement between the two reviewers with regards to the insulin errors extracted from the medication charts and recorded on the error charts.
Length of Stay
Admission and discharge dates were collected manually on all participants. Additional demographic information including admission category, type and management of diabetes, the age and sex of patient, ethnicity, employment status, accommodation, and history of another chronic disease or illness was also collected. LOS was calculated for all admissions (excluding readmissions). This information was collected by the DSN prescriber.
Data collection
Data were collected on admission and at discharge. Admission data included demographic information. Discharge data include medication errors and LOS
Data analysis
SPSS was used for data entry and analysis. Descriptive statistics were used to describe the demographic nature of the sample. X 2 tests were used for categorical data when testing for association. To ensure that cell size reached the recommended minimum of 5 and achieve a reasonable degree of statistical power to detect effect (Pallant 2005) , the 14 insulin and OHA medication errors were reduced in to four categories (Table   2 ). Continuously distributed data were analysed with independent sample t-tests, and the Pearson-moment correlation coefficient.
A general linear modelling procedure was used to explore which if any factors contributed significantly to explaining the variation in the total number of errors and LOS. These factors included age, sex, type of diabetes, time since diagnosis, admission category, management of diabetes, employment, accommodation, and having another chronic disease or illness. The model was then checked using residual analysis.
Ethical considerations
Approval for the study was granted by the research ethics committee of the study hospital and the university with which the principal investigator was affiliated.
Agreement from wards to participate in the study was obtained from ward managers.
A series of staff meetings were held prior to the pre-intervention phase at which details (including information sheets) about the research was disseminated.
RESULTS
Fifty six patients were recruited across both the pre-intervention (n=27) and demographic data in the two study groups were generally similar (Table 3) , although
there is evidence that a greater proportion of patients in the pre-intervention group were treated with insulin and or OHA medication, had been diagnosed with diabetes > 15 years and reported another chronic disease. In comparison a greater proportion of patients in the intervention group were admitted under medicine, and were aged less than 70 years. However results of chi square analysis showed that although there was a significant difference in the type of admission between the two groups, there were no significant differences in the other demographic characteristics i.e. sex, age, Type1/Type 2 diabetes, management of diabetes, ethnicity, employment status, marital status, or accommodation.
Main Outcome measures
Medication Errors
In total medication errors were recorded for 42 patients across both the intervention and pre intervention groups (see Table 2 ).
An independent samples t-test was conducted to compare the total number of errors between groups. There was a significant difference and reduction in the total number of errors between the pre-intervention group (M=26, SD=35.04) and intervention group (M=5.03, SD=7.79; t(47)=2.632 p=0.016). The magnitude of the differences in the means was large (a mean reduction of 21 errors was identified in the intervention group).
Some patients experienced multiple errors. The maximum number of errors recorded for one patient in the pre-intervention group was 130, and in the intervention group the maximum number of errors recorded for one patient was 33. Nurse supplementary prescribing was used in seven patients.
Using a general linear model it was evident that admission type contributed, although not to a significant level (p=0.06) to the total number of errors. A greater number of errors were identified in patients who had been admitted to the surgical wards in both the pre-intervention and intervention group compared to those patients admitted to medicine (see Table 4 ).
Incorrect/ unclear prescribing
An independent samples t-test was conducted to compare the total number of incorrect/unclear prescribing errors between groups. There was no significant difference in the number of incorrect/unclear prescribing errors between the preintervention group (M=6.3, SD=9.5) and intervention group (M=2.2, SD=3.8 t(47)=1.838, p=0.08). A mean reduction of 4 errors was identified in the intervention group.
Charts not signed/ incomplete
An independent samples t-test was conducted to compare the total number charts not signed/incomplete errors between groups. There was no significant difference in the number of charts not signed/incomplete errors between the pre-intervention group (M=3.7, SD=9.0) and intervention group (M=0.28, SD=0.7 t(47)=1.689,p=0.1). A mean reduction of 3.4 errors was identified in the intervention group.
Dose adjustment incorrect/omitted
An independent samples t-test was conducted to compare the total number of dose adjustment incorrect/omitted errors between groups. There was a significant difference in the total number of dose adjustment incorrect/omitted errors between the pre-intervention group (M=2.5, SD=4.2) and intervention group (M=0.21, SD=0.68 t(47)=2.348, p=0.03). A mean reduction of 2.3 errors was identified in the intervention group.
Medicines not signed as given
An independent samples t-test was conducted to compare the total number of medicines not signed as given errors between groups. There was a significant difference and large reduction in the total number of medicines not signed as given Table 5 ).
There was no correlation between the total number of errors, the four error categories and length of stay, age, admission type, type and management of diabetes, ethnicity, employment status, accommodation, and history of another chronic disease or illness.
Length of Stay
In the pre-intervention group the minimum length of stay was three days and the maximum 113 days, compared to a minimum of six and maximum of 52 days in the intervention group. Over half (54%) the patients in the pre-intervention group were in hospital for more than 15 days compared to 42% in the intervention group.
In the pre-intervention group the median length of stay was 17. Using a general linear model it was evident that admission type contributed, although not to a significant level (p=0.42) to length of stay. Patients admitted to the surgical wards in the pre-intervention group experienced a mean length of stay which was more than double than those patients admitted under medicine (see Table 4 ). In order to explore the extremely large difference between LOS and admission type in the preintervention group, a further independent sample t-test was conducted. It was evident from this that admission type had a highly significant effect on LOS for this group of patients (p=0.0004).
A large, positive correlation was found to exist between the length of stay and the total number of errors in the pre-intervention group [r=0.5 n=18, p<0.05]. This effect was not present in the intervention group (See Table 5 ).
A large positive correlation was found between medicines not signed as given errors and length of stay in the pre-intervention group [r=0.53, n=18, p<0.05]. This effect was also present in the intervention group but was less marked, [r=0.4, n=26, p<0.05] (See Table 5 ).
A medium, positive correlation was found to exist between the length of stay and charts not signed/incomplete errors in the pre-intervention group [r=0.49 n=18, p<0.05]. This effect was not present in the intervention group (See Table 5 ).
There was no correlation between length of stay and age, admission type, type and management of diabetes, ethnicity, employment status, accommodation, history of another chronic disease or illness and side effects from medicines for diabetes.
DISCUSSION
Several potential limitations of our methodology need to be taken into account.
Firstly, only patients admitted on to one of the six wards during the three month preintervention phase, and three month intervention period, were included in the study i.e. it was not a random sample. A second potential limitation is that only one DSN prescriber participated in the study. Although this helped with regards to standardising the patient and staff individual education sessions, there is the possibility of character bias.
It is evident from our findings that insulin and OHA errors were recorded for nearly 75% of patients in both the pre-intervention and intervention groups and some patients experienced multiple errors. The 'medicines not signed as given' and 'incorrect/unclear prescribing' categories were the most frequent type of medication errors present on the medicines charts of patients in both the pre-intervention and intervention groups. Our findings suggest that when the medication system failed multiple insulin and OHA medication errors occurred. Specifically, patients who experienced large numbers of 'medicines not signed as given' errors also experienced large numbers of 'charts not signed/incomplete' and 'incorrect unclear' errors.
The median number of total errors in the intervention group was 1 i.e. 10 less than in the pre-intervention group. In addition to having a longer length of stay, this could have been as a result of this group of patients having a longer duration of diabetes requiring more complex drug regimens, and being more likely to be treated with insulin therapy (see Table 3 ). A similar percentage of patients in each group experienced insulin and OHA medication errors. However, it is evident from our findings and the substantial (72%) reduction in errors, that the medicines management intervention provides a system, such as that described by Leape (1994) i.e. it automatically corrects errors and provides a mechanism which detects errors in time for corrective action.
It is evident from our findings that the total number of insulin and OHA medication errors and LOS were affected by admission category. Patients admitted under surgery in both groups experienced a much greater number (2-4 times as many) of insulin and OHA medication errors than those admitted under medicine. In the pre-intervention group, the LOS for patients admitted under surgery was nearly three times that compared to those admitted under medicine.
These findings suggest that the substantially higher number of insulin and OHA errors identified on the medicines charts of surgical patients are more likely to have occurred from a lack of knowledge, or misperception of the situation, with the subsequent application of the wrong rule to the situation as described by Vincent et al. (1998) and Dean et al. (2002) . Furthermore, the higher number of errors had a subsequent detrimental effect in the pre-intervention group with regards to the LOS of patients admitted to these wards. It is possible, therefore that the nursing and medical staff working on the surgical wards may have had less experience and or confidence in managing the medicines of patients for their diabetes than those on medical wards, which ultimately affected the number of insulin and OHA medication errors their patients experienced.
The median LOS for patients in the intervention group was 14.5 days compared to 17.5 days for patients in the pre-intervention group. Based on a cost per patient per day of £250 (DoH 2006b), over one year this is a potential cost saving of £168,000.
Although a number of factors may have affected LOS (e.g. severity of illness, availability of investigations, and response to treatment) a correlation was found to exist, in the pre-intervention group, between LOS and the total number of errors and also between LOS and the error category 'medicines not signed as given' i.e. as the total number of errors increased, so did LOS.
These findings are in-line with those reported by previous research (Wilson et al. 1995 , Classen et al. 1997 , Vincent et al. 2001 . Wilson et al. (1995) in a retrospective review of 14,000 medical records of patients in Australia reported that adverse events accounted for an additional seven hospital bed days per admission, of which 51% were highly preventability. Additionally, cognitive error (including both slips and lapses and mistakes) was deemed to play a part in nearly 60% of these adverse events. More recently in the UK, Vincent et al. (2001) , conducted a retrospective review of 1014 patients records and similarly reported that 50% of adverse events are preventable. Similar findings were reported within the Hospital Trust by James (2003) in a review of hospital patients with poorly controlled diabetes. In this small scale study it was identified that over 50% of the medication errors for the management of diabetes were preventable.
Although not looking at nurse prescribing, a reduction in LOS when care has been provided by DSN has been reported by a number of researchers (Davies et al. 2001 , Cavan et al. 2001 , Koproski et al. 1997 , Sampson et al. 2006 , Courtenay et al. 2007 ) . Sampson et al. (2006) , for example in a study of 14, 722 patients with diabetes, reported the mean excess bed days was significantly lower in patients who received individual structured information and practical management of diabetes from a DSN, compared to those patients who had not.
In line with these findings, and as part our larger study, a reduction in insulin and OHA medication errors was identified in a sample of 452 patients whose medicines were managed by a DSN prescriber (Courtenay et al. 2007) . Furthermore the median length of stay was significantly lower in patients who had received the medicines management intervention compared to those who had not. (2005) suggest must be given to psychological and human factors that contribute to error, particularly the fact that liability to error is strongly affected by the context and conditions of work. It is evident that the medicines management intervention delivered by a DSN prescriber had a dramatic effect on both the medication system and the number of insulin and OHA medication errors patients experienced.
CONCLUSION
In most high-risk industries, learning from accidents or near misses is a long established practice and a cornerstone of safety analysis and improvement. There is substantial evidence to suggest that most incidents involve a chain of problems, and a wide variety of contributing factors that need to be considered. We have shown that the medicines management intervention delivered by a DSN prescriber has a positive effect on the system of delivering medicines to patients with diabetes, and substantially reduced the number of insulin and OHA medication errors. This reduction had some effect on LOS. The reduced LOS of patients in the intervention group produced a cost saving sufficient to fund at least the cost of a DSN prescriber post. 
